M. Valle

2.4k total citations
72 papers, 1.5k citations indexed

About

M. Valle is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Valle has authored 72 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 21 papers in Pulmonary and Respiratory Medicine and 19 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Valle's work include Cardiac Imaging and Diagnostics (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Virology and Viral Diseases (7 papers). M. Valle is often cited by papers focused on Cardiac Imaging and Diagnostics (13 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Virology and Viral Diseases (7 papers). M. Valle collaborates with scholars based in Finland, Spain and Italy. M. Valle's co-authors include M. H. Frick, Irja Davidkin, O Korhola, Markku S. Nieminen, Mikko Paunio, O. P. Heinonen, Heikki Peltola, Christian Ehnholm, T Kuusi and Marja‐Riitta Taskinen and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

M. Valle

70 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Valle Finland 21 479 404 374 333 220 72 1.5k
Tommaso Staniscia Italy 19 404 0.8× 462 1.1× 209 0.6× 64 0.2× 72 0.3× 72 1.9k
Jun‐Jun Yeh Taiwan 23 261 0.5× 338 0.8× 418 1.1× 206 0.6× 83 0.4× 72 1.4k
Irene M. Shui United States 26 204 0.4× 601 1.5× 317 0.8× 123 0.4× 105 0.5× 67 2.2k
Luigi Napolitano Italy 21 290 0.6× 425 1.1× 320 0.9× 83 0.2× 111 0.5× 103 1.5k
Philippe Sogni France 30 710 1.5× 1.8k 4.5× 264 0.7× 143 0.4× 222 1.0× 164 3.2k
Idit F. Schwartz Israel 20 148 0.3× 127 0.3× 204 0.5× 267 0.8× 58 0.3× 71 1.8k
Preeti Jaggi United States 20 728 1.5× 357 0.9× 391 1.0× 425 1.3× 33 0.1× 75 1.8k
Jiří Kettner Czechia 12 198 0.4× 958 2.4× 224 0.6× 491 1.5× 37 0.2× 46 1.8k
Norella Kong Malaysia 21 110 0.2× 256 0.6× 109 0.3× 114 0.3× 162 0.7× 84 1.3k
R. J. P. M. Scholten Netherlands 20 406 0.8× 387 1.0× 207 0.6× 128 0.4× 92 0.4× 48 1.5k

Countries citing papers authored by M. Valle

Since Specialization
Citations

This map shows the geographic impact of M. Valle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Valle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Valle more than expected).

Fields of papers citing papers by M. Valle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Valle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Valle. The network helps show where M. Valle may publish in the future.

Co-authorship network of co-authors of M. Valle

This figure shows the co-authorship network connecting the top 25 collaborators of M. Valle. A scholar is included among the top collaborators of M. Valle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Valle. M. Valle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruíz‐Antorán, Belén, Alicia Gómez‐López, Aránzazu Sancho‐López, et al.. (2022). Bronchopulmonary Penetration of Isavuconazole in Pulmonary Transplant Recipients (PBISA01): Protocol for a Phase IV Clinical Trial With a Single Treatment Arm. JMIR Research Protocols. 11(9). e37275–e37275.
2.
Rubio, Myriam Calle, José Luís López-Campos, José Luís Izquierdo Alonso, et al.. (2022). Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group. Archivos de Bronconeumología. 58(11). 776–779. 1 indexed citations
3.
Calderón‐Parra, Jorge, Elena Múñez, Ana Fernández‐Cruz, et al.. (2021). Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies. Clinical Infectious Diseases. 74(10). 1786–1794. 39 indexed citations
4.
Punekar, Yogesh, Hana Müllerová, Mark Small, et al.. (2016). Prevalence and Burden of Dyspnoea Among Patients with Chronic Obstructive Pulmonary Disease in Five European Countries. Pulmonary Therapy. 2(1). 59–72. 27 indexed citations
5.
6.
Molina, Rosa Malo de, M. Valle, & Piedad Ussetti. (2014). Enfermedad pulmonar obstructiva crónica. Medicine - Programa de Formación Médica Continuada Acreditado. 11(65). 3849–3860. 1 indexed citations
7.
Molina, Rosa Malo de, M. Valle, & Piedad Ussetti. (2014). Protocolo de tratamiento domiciliario del paciente con enfermedad pulmonar obstructiva crónica avanzada. Medicine - Programa de Formación Médica Continuada Acreditado. 11(65). 3894–3900. 1 indexed citations
8.
Yáñez, Aina M., Dolores Guerrero, Rigoberto Pérez de Alejo, et al.. (2012). Monitoring Breathing Rate at Home Allows Early Identification of COPD Exacerbations. CHEST Journal. 142(6). 1524–1529. 85 indexed citations
9.
Melker, Hester E. de, Richard Pebody, W. John Edmunds, et al.. (2001). The seroepidemiology of measles in Western Europe. Epidemiology and Infection. 126(2). 249–259. 53 indexed citations
10.
Pebody, Richard, W. John Edmunds, P Olin, et al.. (2000). The seroepidemiology of rubella in western Europe. Epidemiology and Infection. 125(2). 347–357. 53 indexed citations
11.
Paunio, Mikko, Klaus Hedman, Irja Davidkin, et al.. (2000). Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiology and Infection. 124(2). 263–271. 93 indexed citations
12.
Paunio, Mikko, Heikki Peltola, M. Valle, et al.. (1998). Explosive School-based Measles Outbreak: Intense Exposure May Have Resulted in High Risk, Even among Revaccinees. American Journal of Epidemiology. 148(11). 1103–1110. 76 indexed citations
13.
Pyhälä, Riikka, et al.. (1994). Early kinetics of antibody response to inactivated influenza vaccine. Clinical and Diagnostic Virology. 1(5-6). 271–278. 11 indexed citations
14.
Virtanen, Kari, et al.. (1986). Studies on ergometer exercise testing I. Significance of the type of st‐segment response, sex, and chest pain. Clinical Cardiology. 9(7). 315–322. 7 indexed citations
15.
16.
Järvinen, Antero, et al.. (1983). Sequential internal mammary artery bypass grafts in coronary artery surgery. The Journal of Cardiovascular Surgery. 24(4). 355–356. 5 indexed citations
17.
Valle, M., K. Virtanen, P. Hekali, & M. H. Frick. (1979). Survival with total occlusion of the left main coronary artery. Significance of the collateral circulation. Catheterization and Cardiovascular Diagnosis. 5(3). 269–275. 32 indexed citations
18.
Frick, M. H., et al.. (1976). Analysis of coronary collaterals in ischaemic heart disease by angiography during pacing induced ischaemia.. Heart. 38(2). 186–196. 18 indexed citations
19.
Korhola, O, et al.. (1975). Ischaemic electrocardiographic changes in an athlete with normal coronary arteries.. PubMed. 7(4). 264–8. 2 indexed citations
20.
Valle, M.. (1971). Factors affecting plaque assay of animal viruses--with special reference to vesicular stomatitis and vaccinia virus.. PubMed. 219. Suppl 219:1–69. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tommaso Staniscia Breakdown of academic impact, for papers by Jun‐Jun Yeh Breakdown of academic impact, for papers by Irene M. Shui Breakdown of academic impact, for papers by Luigi Napolitano Breakdown of academic impact, for papers by Philippe Sogni Breakdown of academic impact, for papers by Idit F. Schwartz Breakdown of academic impact, for papers by Preeti Jaggi Breakdown of academic impact, for papers by Jiří Kettner Breakdown of academic impact, for papers by Norella Kong Breakdown of academic impact, for papers by R. J. P. M. Scholten
Rankless by CCL
2026